AYTU BIOPHARMA, INC Loan Processing Fee
AYTU BIOPHARMA, INC (AYTU) reported Loan Processing Fee of $400.00 thousand for the 9-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LoanProcessingFee · last filed 2023-05-11
- AYTU BIOPHARMA, INC loan processing fee for the quarter ending 2023-03-31 was $0.00.
- AYTU BIOPHARMA, INC loan processing fee for the quarter ending 2022-12-31 was $0.00.
- AYTU BIOPHARMA, INC loan processing fee for the quarter ending 2022-09-30 was $400.00K.
- AYTU BIOPHARMA, INC loan processing fee for the quarter ending 2022-06-30 was $0.00.
- AYTU BIOPHARMA, INC loan processing fee for fiscal 2022 was $400.00K.
| Period end | Loan Processing Fee 3 month | Loan Processing Fee 6 month | Loan Processing Fee 9 month | Loan Processing Fee 12 month |
|---|---|---|---|---|
| 2023-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | $0.00 derived: sum of 2 quarters · filed 2023-05-11 | $400.00K 10-Q · filed 2023-05-11 | $400.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-02-21 | $400.00K 10-Q · filed 2023-02-21 | $400.00K derived: sum of 3 quarters · filed 2023-02-21 | |
| 2022-09-30 | $400.00K 10-Q/A · filed 2023-02-21 | $400.00K derived: sum of 2 quarters · filed 2023-02-21 | ||
| 2022-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | $400.00K 10-K · filed 2022-09-27 | ||
| 2022-03-31 | $400.00K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |